RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @TheLancetInfDis: 2) Immunogenicity and safety of a recombinant adenovirus type-5-vectored #COVID19 vaccine in healthy adults aged 18 ye…
RT @TheTrueTankMan: This is big.
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
Las buenas nuevas sobre vacuna y covid19
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @MonsieurQFB: Por la mañana tuvimos la publicación de los resultados de Fase I/II de la vacuna de Oxford - AstraZeneca ( https://t.co/dE…
RT @AlvarezMorenoC: 2) La vacuna #COVID19 vectorizada en adenovirus-5 mostró en un estudio fase 2 en 603 voluntarios, seguridad aceptable…
RT @MonsieurQFB: Por la mañana tuvimos la publicación de los resultados de Fase I/II de la vacuna de Oxford - AstraZeneca ( https://t.co/dE…
RT @SandraRajme: 🔥🔥¡Dos estudios de vacuna en un solo día! ✨Vacuna de vector viral Ad5 contra #SARSCoV2. ✨Segura e inmunógena según lo re…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @MinatoNakazawa: 原著論文は https://t.co/mudsNZi4Uf だが,Lancetの同じ号には,中国発のワクチン候補の第2相臨床試験も安全で有効だったとする原著論文も載っている https://t.co/3iQbFRTGBG 第3相でどうなる…
RT @MinatoNakazawa: 原著論文は https://t.co/mudsNZi4Uf だが,Lancetの同じ号には,中国発のワクチン候補の第2相臨床試験も安全で有効だったとする原著論文も載っている https://t.co/3iQbFRTGBG 第3相でどうなる…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @ChavitoTRD: A pesar de los idiotas que son pocos pero son ruidosos, la civilización logrará superar esta enorme roca. A seguir trabajan…
Good News...👍
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @mayogastro: Excelente. Esta vacuna parece efectiva con pocos efectos 2rios. Immunogenicity and safety of a recombinant adenovirus type-…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
🛑Publicado hoy en @TheLancet Otro ensayo en Fase 2 de vacuna para vector de adenovirus (CanSIno) 🇨🇳: se encontraron anticuerpos neutralizantes de #SARSCoV2 en la mayoría de las personas después de una única dosis y con un buen perfil de seguridad. https
RT @mayogastro: Excelente. Esta vacuna parece efectiva con pocos efectos 2rios. Immunogenicity and safety of a recombinant adenovirus type-…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
@NZStuffPolitics Let’s take recent news about Wuhan Vaccine trial, which the writers indicated had no serious reactions https://t.co/ONSOs5KbIx 74% had side effects at the higher dose (72% had side effects at lower does) 25 had serious grade 3 reactions
Vacuna 🇨🇳 #COVID19 vectorizada ad5, alentador 🧐🤔😷🇲🇽
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @MinatoNakazawa: 原著論文は https://t.co/mudsNZi4Uf だが,Lancetの同じ号には,中国発のワクチン候補の第2相臨床試験も安全で有効だったとする原著論文も載っている https://t.co/3iQbFRTGBG 第3相でどうなるか
RT @juneymb: SURPRISE! ANOTHER VACCINE. https://t.co/EOQuEZ7Z7i
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @mayogastro: Excelente. Esta vacuna parece efectiva con pocos efectos 2rios. Immunogenicity and safety of a recombinant adenovirus type-…
RT @SIDPharm: Check out the phase 1/2 vaccine trials published in @TheLancet today #COVID19 #IDTwitter ChAdOx1 https://t.co/HhLxI684bs Ad…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
Follow the paper published on @TheLancet’s on the latest of a China-developed #COVID19 vaccine - safe and induces an immune responses
RT @infecto79: Resultados muy prometedores de la vacuna con base en vectores "Ad5-vectored COVID-19 vaccine" a dosis de 5 × 10¹⁰ ...en ma…
RT @AB_Algaissi: أخبار جميلة اليوم عن اللقاحات: نشر نتائج المرحلة السريرية ١ للقاح جامعة أكسفورد والنتائج مشجعة جداً. https://t.co/qzBJVYI…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @MonsieurQFB: Por la mañana tuvimos la publicación de los resultados de Fase I/II de la vacuna de Oxford - AstraZeneca ( https://t.co/dE…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @SandraRajme: 🔥🔥¡Dos estudios de vacuna en un solo día! ✨Vacuna de vector viral Ad5 contra #SARSCoV2. ✨Segura e inmunógena según lo re…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @FabBallarini: BUENAS NOTICIAS Se acaban de publicar 2 papers contando los avances sobre 2 vacunas. En ambos casos se muestra respuest…
RT @TheLancet: The primary objective of the study was to evaluate the immune response and safety of the vaccine, and to determine the most…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @aguilar_manuel: Insisto,hay laboratorios (2), que ya han superado las fases I/II, pero aun falta la fase III de investigación. Por lo…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
Second Vaccine data published in The Lancet. Phase 3 trial being planned.
RT @tordoblanco: Una luz certera en el camino. Antes de Navidad tendríamos la vacuna contra covid segura, económica y universal
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @tordoblanco: Una luz certera en el camino. Antes de Navidad tendríamos la vacuna contra covid segura, económica y universal
Otros que dicen que la vacuna suya es la buena:
RT @iaiestaran: Vacuna china en fase 2 resulta segura y produce respuesta inmune en la epidemia de coronavirus #COVID19, según estudio publ…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @MonsieurQFB: Por la mañana tuvimos la publicación de los resultados de Fase I/II de la vacuna de Oxford - AstraZeneca ( https://t.co/dE…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @mayogastro: Excelente. Esta vacuna parece efectiva con pocos efectos 2rios. Immunogenicity and safety of a recombinant adenovirus type-…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pokrath: Ref 1. mRNA vaccine https://t.co/hjEPxcG3sz 2. Oxford vaccine https://t.co/oDJwiMGYwl 3. Cansino vaccine (จีน) https://t.co/Tb…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @pmarsupia: 🔴 Más buenas noticias! The Lancet también ha publicado los resultados de la Fase II de la farmacéutica china CanSino (sí,…
RT @BiotechMania: 中国カンシノ社が開発中のアデノウイルスベクターのCOVID-19ワクチンの第2相試験結果がLancetに掲載。 死亡率が高く最も重要な対象年齢である55歳以上で明らかに免疫反応が劣り、中和抗体陽性抗体価・陽性率が低いことは要注意だろう。 ht…
3/3. Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial https://t.co/nrNF7FmY6I
RT @DrNecmettinUnal: Bu gün Lancette iki ayrı #covid19 aşısı ile alakalı makale yayınlandı. İlki Oxford'dan Faz1/2, ikincisi Çinden Faz2 ar…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @Vic_Gill: 7 months ago, scientists in China published the genetic code for SARS-CoV-2. The speed of this achievement blows my mind. Sc…
RT @MonsieurQFB: Por la mañana tuvimos la publicación de los resultados de Fase I/II de la vacuna de Oxford - AstraZeneca ( https://t.co/dE…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…
RT @AB_Algaissi: أخبار جميلة اليوم عن اللقاحات: نشر نتائج المرحلة السريرية ١ للقاح جامعة أكسفورد والنتائج مشجعة جداً. https://t.co/qzBJVYI…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
RT @TheLancet: Just added to The Lancet's #COVID19 Resource Centre—Safety and immunogenicity of two COVID-19 vaccine trials: ChAdOx1 https:…
Here We Are....Immunogenicity and safety of a recombinant adenovirus type-5-vectored COVID-19 vaccine in healthy adults aged 18 years or older: a randomised, double-blind, placebo-controlled, phase 2 trial https://t.co/Q6VamkQ8xV
7-20-2020: Here's the complete information from Lancet for the CanSino and the Oxford/AstraZeneca COVID-19 vaccines, which might protect humans adequately for just the first 2 months: https://t.co/mdSqJ37Swt https://t.co/LOvAzgmjrN https://t.co/UMuHvwDaLS
RT @AlvarezMorenoC: 2) La vacuna #COVID19 vectorizada en adenovirus-5 mostró en un estudio fase 2 en 603 voluntarios, seguridad aceptable…
RT @TheLancet: NEW—Chinese phase 2 trial finds #COVID19 vaccine is safe and induces an immune response https://t.co/y19Tg7VmUT https://t.co…